Ping An Biomedical Co., Ltd.
PASW · XNASCIK 1897532fmd_014BF4CWYWMF1GJXHGYQ8WGK9NManufacturing · Apparel & Other Finishd Prods of Fabrics & Similar MatlTemplate: Standard
Coverage: Oct 01, 2022 to Sep 30, 2025, 5 periods
Latest annual · FY2025
Millions- Total revenues
- 34
- Gross profit
- 1
- Operating income
- (15)
- Net income
- (13)
Daily close · PASWIEX trades only
Nov 09, 2026 to Nov 10, 2026 · 2 sessions1.33 USD
Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.
Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms
Ping An Biomedical Co., Ltd. (PASW) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | CN¥34.1 million | CN¥87.6 million | -61% | 20-F 2026-01-30 · proof |
| Gross profit | CN¥949,505 | CN¥5.4 million | -82.5% | 20-F 2026-01-30 · proof |
| Operating income | -CN¥14.7 million | -CN¥2,039 | 20-F 2026-01-30 · proof | |
| Net income | -CN¥12.8 million | -CN¥1.3 million | 20-F 2026-01-30 · proof | |
| Cash from operating activities | -CN¥6.4 million | CN¥14.6 million | -143.9% | 20-F 2026-01-30 · proof |
| Total assets | CN¥68.4 million | CN¥56.8 million | +20.3% | 20-F 2026-01-30 · proof |
| Total liabilities | CN¥23.2 million | CN¥64 million | -63.8% | 20-F 2026-01-30 · proof |
| Cash and cash equivalents | CN¥1.2 million | CN¥130,923 | +795.5% | 20-F 2026-01-30 · proof |
- What was Ping An Biomedical Co., Ltd. (PASW)'s revenue in fiscal 2025?
- Ping An Biomedical Co., Ltd. (PASW) reported revenue of CN¥34.1 million for fiscal 2025 (the year ended Sep 30, 2025), against CN¥87.6 million the year before (-61%). Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
- What was Ping An Biomedical Co., Ltd. (PASW)'s gross profit in fiscal 2025?
- Ping An Biomedical Co., Ltd. (PASW) reported gross profit of CN¥949,505 for fiscal 2025 (the year ended Sep 30, 2025), against CN¥5.4 million the year before (-82.5%). Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
- What was Ping An Biomedical Co., Ltd. (PASW)'s operating income in fiscal 2025?
- Ping An Biomedical Co., Ltd. (PASW) reported operating income of -CN¥14.7 million for fiscal 2025 (the year ended Sep 30, 2025), against -CN¥2,039 the year before. Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
- What was Ping An Biomedical Co., Ltd. (PASW)'s net income in fiscal 2025?
- Ping An Biomedical Co., Ltd. (PASW) reported net income of -CN¥12.8 million for fiscal 2025 (the year ended Sep 30, 2025), against -CN¥1.3 million the year before. Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
- What was Ping An Biomedical Co., Ltd. (PASW)'s cash from operating activities in fiscal 2025?
- Ping An Biomedical Co., Ltd. (PASW) reported cash from operating activities of -CN¥6.4 million for fiscal 2025 (the year ended Sep 30, 2025), against CN¥14.6 million the year before (-143.9%). Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
- What are Ping An Biomedical Co., Ltd. (PASW)'s total assets?
- As of Sep 30, 2025, Ping An Biomedical Co., Ltd. (PASW) reported total assets of CN¥68.4 million, against CN¥56.8 million a year earlier (+20.3%). Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
- What are Ping An Biomedical Co., Ltd. (PASW)'s total liabilities?
- As of Sep 30, 2025, Ping An Biomedical Co., Ltd. (PASW) reported total liabilities of CN¥23.2 million, against CN¥64 million a year earlier (-63.8%). Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
- What are Ping An Biomedical Co., Ltd. (PASW)'s cash and cash equivalents?
- As of Sep 30, 2025, Ping An Biomedical Co., Ltd. (PASW) reported cash and cash equivalents of CN¥1.2 million, against CN¥130,923 a year earlier (+795.5%). Source: the 20-F filed with the SEC on Jan 30, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:PASW&period_type=annual&limit=5"Information only, not investment advice.